Corpus Intelligence IC Memo — SSH - SOUTHEAST OHIO 2026-04-26 13:47 UTC
IC Memo — SSH - SOUTHEAST OHIO
Investment Committee Memorandum | OH | 35 beds | Grade C | EBITDA uplift $1.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SSH - SOUTHEAST OHIO

CCN 362031 | LICKING, OH | 35 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SSH - SOUTHEAST OHIO is a 35-bed suburban community hospital in LICKING, OH with $17.1M in net patient revenue and a 9.3% operating margin. The hospital serves a payer mix of 43.2% Medicare, 7.1% Medicaid, and 49.7% commercial.

Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.3% to 16.6% (+736bps).

Net Revenue HCRIS$17.1M
Current EBITDA COMPUTED$1.6M
Operating Margin COMPUTED9.3%
Occupancy HCRIS68.8%
Revenue / Bed COMPUTED$488K
Net-to-Gross HCRIS15.7%
Distress Probability ML44.5%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
100
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 9.3% places it above the state median. Among 100 size-comparable peers (18-70 beds), the median margin is -1.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-70), prioritizing same-state peers. 100 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSH - SOUTHEAST OHIO (Target)OH35$17.1M9.3%
KNOX COMMUNITY HOSPITALOH64$196.0M-16.7%
CRYSTAL CLINIC ORTHOPAEDIC CENOH59$173.3M-14.9%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
OBLENESS MEMORIAL HOSPITALOH67$160.9M29.9%
MEMORIAL HOSPITAL OF UNION COUOH51$151.0M8.0%
GRADY MEMORIAL HOSPITALOH60$146.7M16.5%
GALION COMMUNITY HOSPITALOH25$128.2M16.6%
MARY RUTAN HOSPITALOH39$113.0M-12.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$359K+210bp18mo
Cost to Collect4.5%2.5%$342K+200bp12mo
Denial Rate Reduction12.0%6.5%$338K+198bp12mo
A/R Days Reduction5200.0%3800.0%$208K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$359K
Cost to Collect
$342K
Denial Rate Reduction
$338K
A/R Days Reduction
$208K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.3M
Current EBITDA$1.6M
+ RCM Uplift+$1.3M
Pro Forma EBITDA$2.8M
Current Margin9.3%
Pro Forma Margin16.6%
WC Released (1x)$655K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.4M$23.0M9.45x56.7%
Base (11x exit)10.0x11.0x$2.4M$26.1M10.72x60.7%
Bull Case9.0x11.0x$2.2M$31.0M14.17x69.9%
Bull (12x exit)9.0x12.0x$2.2M$34.5M15.75x73.6%
Bear Case11.0x10.0x$2.7M$15.9M5.95x42.9%
Bear (11x exit)11.0x11.0x$2.7M$18.4M6.87x47.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 100 hospitals with 18-70 beds
  • Same-state prioritization (n=101)
  • Comp margins: P25=-11.1% / P50=-1.7% / P75=12.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.